Space & Defense entity

Vuzix Corporation

Company VUZI

Every one of those 1 sits in a single category, aerospace. Of the tracked stories, 1 of 1 also mention Aemetis, the most common co-covered peer. Source depth averages 15 original sources per story, versus 2.9 across the same-window beat baseline.

Last mentioned: Mar 13, 2026

Entity pulse

Recent coverage · Vuzix Corporation

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Vuzix Corporation

Every one of those 1 sits in a single category, aerospace. Of the tracked stories, 1 of 1 also mention Aemetis, the most common co-covered peer. Source depth averages 15 original sources per story, versus 2.9 across the same-window beat baseline. The 7 average consequence score is above the beat benchmark of 6.8 in the same window. We currently track 1 Space & Defense story that mention Vuzix Corporation, all published on March 13, 2026.

Stories tracked
1
Sources per story
15

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 26 Space & Defense stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Vuzix Corporation. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Lorundrostat PDUFA Date

    Target date for FDA decision on Mineralys' lead product candidate.

  2. Nektar Phase 3 Launch

    Nektar plans first patient randomization for its Atopic Dermatitis program.

  3. Mineralys NDA Acceptance

    FDA accepts Mineralys' NDA for lorundrostat for uncontrolled hypertension.

  4. EHang Record Deliveries

    EHang closes Q4 with 100 eVTOL units delivered and first GAAP profit.

  5. HeartBeam FDA Clearance

    HeartBeam secures 510(k) clearance for 12-lead ECG synthesis software.

Stories mentioning Vuzix Corporation 1

Vuzix Corporation is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.